• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Pulmonary and Immune Dysfunction in Pediatric Long COVID: A Case Study Evaluating the Utility of ChatGPT-4 for Analyzing Scientific Art

tetano

Editor, Senior Moderator
J Clin Med


. 2025 Aug 25;14(17):6011.
doi: 10.3390/jcm14176011. Pulmonary and Immune Dysfunction in Pediatric Long COVID: A Case Study Evaluating the Utility of ChatGPT-4 for Analyzing Scientific Articles

Susanna R Var[SUP] 1 2 [/SUP], Nicole Maeser[SUP] 3 [/SUP], Jeffrey Blake[SUP] 4 [/SUP], Elise Zahs[SUP] 4 [/SUP], Nathan Deep[SUP] 4 [/SUP], Zoey Vasilakos[SUP] 4 [/SUP], Jennifer McKay[SUP] 5 [/SUP], Sether Johnson[SUP] 1 2 [/SUP], Phoebe Strell[SUP] 1 2 6 [/SUP], Allison Chang[SUP] 7 [/SUP], Holly Korthas[SUP] 8 [/SUP], Venkatramana Krishna[SUP] 9 [/SUP], Manojkumar Narayanan[SUP] 9 [/SUP], Tuhinur Arju[SUP] 9 [/SUP], Dilmareth E Natera-Rodriguez[SUP] 1 2 [/SUP], Alex Roman[SUP] 7 [/SUP], Sam J Schulz[SUP] 5 [/SUP], Anala Shetty[SUP] 1 2 [/SUP], Mayuresh Vernekar[SUP] 4 [/SUP], Madison A Waldron[SUP] 7 [/SUP], Kennedy Person[SUP] 7 [/SUP], Maxim Cheeran[SUP] 9 [/SUP], Ling Li[SUP] 7 8 10 [/SUP], Walter C Low[SUP] 1 2 3 4 6 7 10 11 [/SUP]



Affiliations
Abstract

Coronavirus disease 2019 (COVID-19) in adults is well characterized and associated with multisystem dysfunction. A subset of patients develop post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID), marked by persistent and fluctuating organ system abnormalities. In children, distinct clinical and pathophysiological features of COVID-19 and long COVID are increasingly recognized, though knowledge remains limited relative to adults. The exponential expansion of the COVID-19 literature has made comprehensive appraisal by individual researchers increasingly unfeasible, highlighting the need for new approaches to evidence synthesis. Large language models (LLMs) such as the Generative Pre-trained Transformer (GPT) can process vast amounts of text, offering potential utility in this domain. Earlier versions of GPT, however, have been prone to generating fabricated references or misrepresentations of primary data. To evaluate the potential of more advanced models, we systematically applied GPT-4 to summarize studies on pediatric long COVID published between January 2022 and January 2025. Articles were identified in PubMed, and full-text PDFs were retrieved from publishers. GPT-4-generated summaries were cross-checked against the results sections of the original reports to ensure accuracy before incorporation into a structured review framework. This methodology demonstrates how LLMs may augment traditional literature review by improving efficiency and coverage in rapidly evolving fields, provided that outputs are subjected to rigorous human verification.

Keywords: ChatGPT; SAR-CoV-2; artificial intelligence; coronavirus; immune dysfunction; large language model; long COVID; pediatric population; post-acute sequelae of COVID-19; pulmonary dysfunction.

 
Back
Top